Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Race Oncology Ltd. ( (AU:RAC) ) is now available.
Race Oncology Ltd announced the cessation of 558,040 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This cessation may impact the company’s capital structure and could have implications for its stakeholders, reflecting on its operational and strategic positioning within the biotechnology sector.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies.
Average Trading Volume: 134,324
Technical Sentiment Signal: Sell
Current Market Cap: A$222.4M
For a thorough assessment of RAC stock, go to TipRanks’ Stock Analysis page.